Keyphrases
Doxorubicin-induced Cardiotoxicity
44%
Aging
44%
Pathophysiological Mechanisms
44%
Accelerated Aging
44%
Aging Phenotype
44%
Chronic Heart Failure
44%
Patients with Heart Failure
44%
Digoxin
44%
Netherlands
44%
Doxorubicin
29%
Cellular Senescence
14%
Cancer Therapy
14%
Long-term Adverse Effects
14%
Aging Heart
14%
Treatment Strategy
14%
Cancer Patients
14%
Heart Failure
14%
Clinical Setting
14%
Cancer Survivors
14%
Healthcare
14%
Cancer Therapeutics-related Cardiac Dysfunction
14%
Drug Development
14%
Heart Failure Hospitalization
11%
Left Ventricular Ejection Fraction
11%
Hospital Visits
7%
Cardiovascular Mortality
7%
Heart Failure Treatment
7%
Mild Reduction
7%
Pharmacology, Toxicology and Pharmaceutical Science
Heart Failure
100%
Malignant Neoplasm
44%
Doxorubicin
44%
Cardiotoxicity
44%
Inflammation
44%
Disease Severity
44%
Interleukin 17
44%
Digoxin
44%
Side Effect
11%
Placebo
10%
Cardiovascular Mortality
6%
Medicine and Dentistry
Heart Failure
55%
Doxorubicin
44%
Cardiotoxicity
44%
Interleukin 17
44%
Serositis
44%
Disease Severity
44%
Accelerated Aging
33%
Cancer Therapy
22%
Malignant Neoplasm
22%
Cellular Senescence
11%
Side Effect
11%